THAR — Tharimmune Balance Sheet
0.000.00%
- $19.54m
- $17.55m
Annual balance sheet for Tharimmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.192 | 0.004 | 6.51 | 10.9 | 3.56 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.295 | 0.622 | 6.69 | 10.9 | 3.72 |
| Total Assets | 0.295 | 0.622 | 6.69 | 10.9 | 3.72 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.73 | 4.53 | 1.14 | 1.82 | 2.41 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 4.01 | 5.31 | 1.14 | 1.82 | 2.41 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | -3.72 | -4.68 | 5.54 | 9.13 | 1.31 |
| Total Liabilities & Shareholders' Equity | 0.295 | 0.622 | 6.69 | 10.9 | 3.72 |
| Total Common Shares Outstanding |